Regular Aspirin Use Reduces Risk of Dying from Colorectal Cancer

Regular use of aspirin after colorectal cancer diagnosis may reduce the risk of cancer death, report investigators from Mass. General, Dana-Farber and Brigham and Women's. The study's authors also find that the aspirin-associated survival advantage was seen primarily in patients with tumors expressing the COX-2 enzyme, a characteristic of two-thirds of colorectal cancers.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews